Losing your nerves? Maybe it's the antibodies
- 1 June 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Reviews Immunology
- Vol. 9 (6), 449-456
- https://doi.org/10.1038/nri2529
Abstract
In this Opinion article, Betty Diamond and colleagues propose that common serum antibodies that crossreact with brain antigens might be responsible for many acquired changes or congenital impairments in cognition and behaviour in the absence of overt brain inflammation. We propose that the normal immunocompetent B cell repertoire is replete with B cells making antibodies that recognize brain antigens. Although B cells that are reactive with self antigen are normally silenced during B cell maturation, the blood–brain barrier (BBB) prevents many brain antigens from participating in this process. This enables the generation of a B cell repertoire that is sufficiently diverse to cope with numerous environmental challenges. It requires, however, that the integrity of the BBBs is uninterrupted throughout life to protect the brain from antibodies that crossreact with microorganisms and brain antigens. Under conditions of BBB compromise, and during fetal development, we think that these antibodies can alter brain function in otherwise healthy individuals.Keywords
This publication has 84 references indexed in Scilit:
- Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunityBrain, 2004
- Signaling the brain in systemic inflammation: role of sensory circumventricular organsFrontiers in Bioscience-Landmark, 2004
- Endothelium and the brain in CNS lupusLupus, 2003
- Paraneoplastic Syndromes Involving the Nervous SystemThe New England Journal of Medicine, 2003
- Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitisBrain, 2003
- Maternal neuronal antibodies associated with autism and a language disorderAnnals of Neurology, 2003
- Autoantibodies to ion channels at the neuromuscular junctionAutoimmunity Reviews, 2003
- High-Dose Intravenous Immune Globulin for Stiff-Person SyndromeThe New England Journal of Medicine, 2001
- A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosusNature Medicine, 2001
- Mediated efflux of IgG molecules from brain to blood across the blood–brain barrierJournal of Neuroimmunology, 2001